In 2023, Mark A. Velleca, M.D., Ph.D. earned $244.28K in total compensation at Black Diamond Therapeutics, Inc., primarily from $180.33K salary. Most recently sold 60,000 shares in Aug 2023. Currently holds stock worth $335.40K. Has donated $7.15K in stock to charitable causes. 2+ years at the helm of Black Diamond Therapeutics, Inc..
Compensation History
Annual executive compensation data for Mark A. Velleca, M.D., Ph.D., including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$244.28K
Salary
$180.33K
Bonus
$0.00
Other
$63.95K
Salary
$180.33KBoard Justification
The compensation philosophy is based on a pay-for-performance model, aligning executive compensation with company performance and market benchmarks.
Bonus
$0.00Board Justification
No bonus was awarded for 2023 as the CEO position was held for part of the year only.
Other Compensation
$63.95KBoard Justification
This includes a 401(k) matching contribution and a $6,000 annual stipend for personal expenses.
Restricted Stock
Board Justification
No stock awards vested in 2023 as the stock options granted were not specified to have vested during the year.
Performance Metrics
Performance metrics for determining compensation include corporate goals related to financial and operational measures.
Mark A. Velleca, M.D., Ph.D.
CEO of Black Diamond Therapeutics, Inc.
Education
M.D. and Ph.D. from Washington University in St. Louis
Field of Expertise
Healthcare & Life Sciences - Biotechnology
Sector of Economy
Healthcare
Born
January 1, 1973 - 52 years ago
CEO of Black Diamond Therapeutics, Inc. for
2 years 2 months (Sep 2023 - Present)
Previous Experience
Former CEO of G1 Therapeutics, Inc.
Other Black Diamond Therapeutics, Inc. CEOs
Holdings
Track Mark A. Velleca, M.D., Ph.D.'s stock holdings and portfolio value over time.
Total Stock Sold
$8.92M
$8.92M
456,040 GTHX shares
What if they kept their stock?
If Mark A. Velleca, M.D., Ph.D. didn't sell their stock, today they would have:
Extra GTHX456,040 shares worth $3.26M.
This is -63.44% and $5.66M less than what they got when they sold the stock.
Charitable Transactions
1,000 shares
GTHX
Recent Charitable Transactions
1,000 shares
GTHX
Jul 16, 2018
Charity
Insider Trading
Mark A. Velleca, M.D., Ph.D.'s recent stock transactions, purchases, and sales filed with the SEC.
$120.56K
GTHX at $2.01/share
Aug 8, 2023
Sale
$175.49K
GTHX at $11.70/share
Oct 18, 2022
Sale
$270.04K
GTHX at $13.50/share
Sep 20, 2022
Sale
$1.01M
GTHX at $12.64/share
Aug 16, 2022
Sale
$570.26K
GTHX at $19.01/share
Jul 13, 2021
Sale
$659.02K
GTHX at $21.97/share
Jun 15, 2021
Sale
$597.10K
GTHX at $19.90/share
May 11, 2021
Sale
$733.77K
GTHX at $24.46/share
Apr 13, 2021
Sale
$983.48K
GTHX at $31.68/share
Feb 16, 2021
Sale
$630.29K
GTHX at $21.01/share
Jan 19, 2021
Sale
Rivals
Compare Mark A. Velleca, M.D., Ph.D. with competitor CEOs and industry peers.